No Picture
News

Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time

SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of ob… […]

No Picture
News

Abzena Announces Successful Technical Transfer of Synaffix GlycoConnect? Antibody Drug Conjugate (ADC) Technology to Enable Use in Client Projects

SAN DIEGO–(BUSINESS WIRE)–Abzena, the global partner research organization, announced it has successfully completed a technology transfer and scalability evaluation using the Synaffix technologies of GlycoConnect? (antibody conjugation) and HydraSpac… […]

No Picture
News

Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update

LA JOLLA, Calif., July 15, 2019 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial resu… […]